BMS-JPM-2025-presentation

43rd Annual J.P. Morgan Healthcare ConferenceJanuary 13th, 2025Christopher Boerner, Ph.D., Board Chair and Chief Executive OfficerForward Looking Statements and Non-GAAP Financial Information2This presentation (as well as the oral statements made with respect to the information contained in this presentation) contains statements about Bristol-Myers Squibb Company’s (the “Company”) future financial results, plans, business development strategy, anticipated clinical trials, results and regulatory approvals that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Actual results may differ materially from those expressed in, or implied by, these statements as a result of various factors, including, but not limited to: (i) New laws and regulations, (ii) Our ability to obtain, protect and m